Emd Millipore Corporation v. Allpure Technologies, Inc.

768 F.3d 1196, 112 U.S.P.Q. 2d (BNA) 1412, 2014 U.S. App. LEXIS 18530, 2014 WL 4800081
CourtCourt of Appeals for the Federal Circuit
DecidedSeptember 29, 2014
Docket2014-1140
StatusPublished
Cited by14 cases

This text of 768 F.3d 1196 (Emd Millipore Corporation v. Allpure Technologies, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Emd Millipore Corporation v. Allpure Technologies, Inc., 768 F.3d 1196, 112 U.S.P.Q. 2d (BNA) 1412, 2014 U.S. App. LEXIS 18530, 2014 WL 4800081 (Fed. Cir. 2014).

Opinion

PROST, Chief Judge.

Plaintiffs-Appellants EMD Millipore Corporation, formerly known as Millipore Corporation; Merck Chemicals and Life Science AB, formerly known as Millipore AB; and Millipore SAS (collectively, “Millipore”) appeal the grant of summary judgment that Defendantr-Appellee AllPure Technologies, Inc., now known as AllPure Technologies LLC, (“AllPure”) does not infringe the asserted claims of U.S. Patent No. 6,032,543 (“'543 patent”). See EMD Millipore Corp. v. AllPure Techs., Inc., No. 11-10221, 2013 WL 5299372 (D.Mass. Sept. 17, 2013) (“Summary Judgment Order”). The district court found that All-Pure’s TAKEONE device neither literally contains the claimed “removable, replaceable transfer member,” nor does it provide an infringing equivalent. Id. at *9. We agree with the district court that the TAKEONE device does not literally inflinge. We also conclude that prosecution history estoppel prevents Millipore from asserting the doctrine of equivalents as to this claim limitation. On these grounds, we affirm the district court’s grant of summary judgment.

I. Background

Millipore owns the rights to the '543 patent, which discloses a device for introducing or withdrawing a sample from a container holding a fluid without contaminating the fluid. See '543 patent abstract, col. 2 11. 20-24. As Figure 5 depicts, the claimed device is attached to the side of a container holding a fluid medium. Id. at col. 1 11. 54-56.

*1199 [[Image here]]

To avoid contamination problems, the '543 patent uses individual transfer members to maintain a closed system. '543 patent col. 5 11. 20-23, col. 5 11. 35-39, col. 6 11. 23-26. Each transfer member has a needle embedded in a plastic holder and a seal surrounding the needle which attaches to the holder. '543 patent col. 3 11.11-35.

The '543 patent contains 14 claims, including 1 independent claim. Independent claim 1 is reproduced below:

1. A device for one of introduction and withdrawal of a medium into a container having an aperture formed therein for receiving said device, said device comprising:
at least one removable, replaceable transfer member for transferring a medium into and out of the container, said transfer member comprising a holder, a seal for sealing said aperture, a hypodermic needle having a tip, said needle supported within said holder in a longitudinal direction thereof, wherein the seal has a first end comprised of a bellows-shaped part sealingly attached to said holder, and a second end comprising a self-sealing membrane portion interiorly formed at an end of said bellows part, said membrane portion for sealing said aperture of said container, wherein said bellows-shaped part surrounds said needle and is deformable in a longitudinal direction, said membrane portion pierceable by the tip of the needle to form a sealable channel;
a fastening device for sealingly securing the transfer member via the seal with the aperture of the container, thereby forming a closed system, said fastening device comprising a flanged part sealingly secured in the aperture and formed with at least one hole therethrough in communication with an interior of said container, a magazine part for removable securement of said at least one transfer member, and a fastening and centering means for removable locking of the magazine part to a flanged part in a position wherein the membrane portion sealingly abuts against the hole of the flanged part so as to accept the hypodermic needle for introduction into *1200 and withdrawal from the container through the membrane portion and the hole.

/C43 patent, claim 1 (emphases added).

AllPure’s accused TAKEONE device is an aseptic sampling system that may be attached to the outside of a container holding a fluid medium and has cannulas that can be inserted into the container to withdraw a sample. The device is delivered fully assembled and sterilized, and it is intended to be disposed of following use. The TAKEONE device, in a disassembled state, is shown below. Summary Judgment Order at *7. The TAKEONE device’s transfer member (130) is composed of a holder (150), a seal (comprising a bellows-shaped part (165) and a membrane (166)), and needles (170). Id. When disassembled, all components of the TAKEONE device’s transfer member can be removed from the magazine part (135). Id.

[[Image here]]

The district court granted AllPure’s motion for summary judgment of no infringement of the '543 patent, finding that “the TAKEONE device lacks a ‘removable, replaceable transfer member’ as claimed in the '543 patent.” Summary Judgment Order at *7-8. The district court rejected Millipore’s argument that a disassembled TAKEONE device satisfies this claim limitation. Id. at *8. The district court also found that the TAKEONE device does not provide an infringing equivalent of the limitation. Id. 1 We have jurisdiction pursuant to 28 U.S.C. § 1295(a)(1).

III. Standards of Review

Summary judgment is appropriate when there is “no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed.R.Civ.P. 56(a). While we review summary judgment decisions de novo, Innogenetics, N.V. v. Abbott Labs., 512 F.3d 1363, 1378 (Fed.Cir.2008), “infringement, whether literal or under the doctrine of *1201 equivalents, is a question of fact.” Bai v. L & L Wings, Inc., 160 F.3d 1350, 1353 (Fed.Cir.1998). However, “a court may determine infringement on summary judgment “when no reasonable jury could find that every limitation recited in the properly construed claim either is or is not found in the accused device.’ ” Innovention Toys, LLC v. MGA Entmn’t, Inc., 637 F.3d 1314, 1319 (Fed.Cir.2011) (quoting Bai 160 F.3d at 1353).

Whether prosecution history estoppel applies to a particular argument, and thus whether the doctrine of equivalents is available for a particular claim limitation, is a question of law reviewed de novo. Intervet Inc. v. Merial Ltd,., 617 F.3d 1282, 1290-91 (Fed.Cir.2010).

IV. Discussion

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ottah v. Bracewell LLP
S.D. New York, 2021
Riddell, Inc. v. Kranos Corp.
319 F. Supp. 3d 1071 (E.D. Illinois, 2018)
Edge Systems LLC v. Aguila
186 F. Supp. 3d 1330 (S.D. Florida, 2016)
Stopinc Aktiengesellschaft v. J.W. Hicks, Inc.
131 F. Supp. 3d 763 (N.D. Indiana, 2015)
UCB, Inc. v. Yeda Research & Development Co.
117 F. Supp. 3d 755 (E.D. Virginia, 2015)
Changzhou Kaidi Electrical Co. v. Okin America, Inc.
102 F. Supp. 3d 740 (D. Maryland, 2015)
Malibu Boats, LLC v. Nautique Boat Co.
122 F. Supp. 3d 722 (E.D. Tennessee, 2015)
East Coast Sheet Metal Fabricating Corp. v. Autodesk
2015 DNH 011 (D. New Hampshire, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
768 F.3d 1196, 112 U.S.P.Q. 2d (BNA) 1412, 2014 U.S. App. LEXIS 18530, 2014 WL 4800081, Counsel Stack Legal Research, https://law.counselstack.com/opinion/emd-millipore-corporation-v-allpure-technologies-inc-cafc-2014.